SU1165223A3 - Способ получени эргоалкалоидов - Google Patents
Способ получени эргоалкалоидов Download PDFInfo
- Publication number
- SU1165223A3 SU1165223A3 SU762412401A SU2412401A SU1165223A3 SU 1165223 A3 SU1165223 A3 SU 1165223A3 SU 762412401 A SU762412401 A SU 762412401A SU 2412401 A SU2412401 A SU 2412401A SU 1165223 A3 SU1165223 A3 SU 1165223A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- ergoalkaloids
- methanesulfonate
- mixture
- fact
- flask
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2546577A DE2546577B2 (de) | 1975-10-17 | 1975-10-17 | Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden |
Publications (1)
Publication Number | Publication Date |
---|---|
SU1165223A3 true SU1165223A3 (ru) | 1985-06-30 |
Family
ID=5959411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU762412401A SU1165223A3 (ru) | 1975-10-17 | 1976-10-15 | Способ получени эргоалкалоидов |
Country Status (28)
Country | Link |
---|---|
JP (1) | JPS5854122B2 (ja) |
AT (1) | AT362510B (ja) |
AU (1) | AU508628B2 (ja) |
BE (1) | BE847368A (ja) |
CA (1) | CA1079641A (ja) |
CH (1) | CH643737A5 (ja) |
CS (1) | CS199647B2 (ja) |
DE (1) | DE2546577B2 (ja) |
DK (1) | DK146194C (ja) |
ES (1) | ES452420A1 (ja) |
FI (1) | FI762875A (ja) |
FR (1) | FR2327764A1 (ja) |
GB (1) | GB1560406A (ja) |
GR (1) | GR61268B (ja) |
HK (1) | HK3183A (ja) |
HU (1) | HU172533B (ja) |
IE (1) | IE43778B1 (ja) |
IL (1) | IL50686A (ja) |
MY (1) | MY8400063A (ja) |
NL (1) | NL184558C (ja) |
NO (1) | NO144468C (ja) |
NZ (1) | NZ182341A (ja) |
PH (1) | PH14513A (ja) |
PT (1) | PT65719B (ja) |
SE (1) | SE430379B (ja) |
SG (1) | SG63082G (ja) |
SU (1) | SU1165223A3 (ja) |
ZA (1) | ZA766166B (ja) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1572226A (en) * | 1977-11-03 | 1980-07-30 | Hoechst Uk Ltd | Pharmaceutical preparations in solid unit dosage form |
US4411882A (en) | 1978-12-21 | 1983-10-25 | Sandoz Ltd. | Galenical compositions |
DK154607C (da) * | 1978-12-21 | 1989-06-05 | Sandoz Ag | Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider |
FR2454804B1 (fr) * | 1979-04-26 | 1986-11-21 | Sanofi Sa | Medicament a base de dihydroergotoxine et son procede de preparation |
US4366145A (en) * | 1981-06-24 | 1982-12-28 | Sandoz, Inc. | Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation |
US4898729A (en) * | 1983-12-09 | 1990-02-06 | Euroceltique, S.A. | Treatment of hypertension, compounds and compositions for antihypertension and diuresis |
HU198844B (en) * | 1984-06-14 | 1989-12-28 | Sandoz Ag | Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient |
EP0277092B1 (de) * | 1987-01-14 | 1992-01-29 | Ciba-Geigy Ag | Therapeutisches System für schwerlösliche Wirkstoffe |
FR2610827B1 (fr) * | 1987-02-18 | 1991-09-13 | Pf Medicament | Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication |
US5064656A (en) * | 1989-11-14 | 1991-11-12 | Dr. Gergely & Co. | Uncoated pharmaceutical reaction tablet |
DE4401646A1 (de) * | 1994-01-21 | 1995-07-27 | Krewel Werke Gmbh | Optimal freisetzende Kava-Extrakte |
US6524832B1 (en) | 1994-02-04 | 2003-02-25 | Arch Development Corporation | DNA damaging agents in combination with tyrosine kinase inhibitors |
US6632455B2 (en) | 1997-12-22 | 2003-10-14 | Schering Corporation | Molecular dispersion composition with enhanced bioavailability |
PE20000012A1 (es) * | 1997-12-22 | 2000-01-18 | Schering Corp | Composicion para dispersion molecular con biodisponibilidad aumentada |
US6316462B1 (en) | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
US7771746B2 (en) | 1999-12-03 | 2010-08-10 | Polichem Sa | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
CA2393344C (en) * | 1999-12-03 | 2009-09-01 | Polichem S.A. | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
US7135436B2 (en) | 2003-05-05 | 2006-11-14 | J.F. Daley International, Ltd. | Solid algicide, preparation and usage in recirculating water |
EP1638527B1 (en) * | 2003-06-27 | 2006-10-25 | BIOPROGRESS S.p.A. | Composite product obtainable by cogrinding of an active principle with a copolymer n-vinyl-2-pyrrolidone/vinyl-acetate |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1175430A (en) * | 1966-04-07 | 1969-12-23 | Sandoz Ltd | Pharmaceutical Compositions containing Ergot Alkaloids |
-
1975
- 1975-10-17 DE DE2546577A patent/DE2546577B2/de not_active Withdrawn
-
1976
- 1976-10-01 CH CH1244876A patent/CH643737A5/de not_active IP Right Cessation
- 1976-10-08 SE SE7611189A patent/SE430379B/xx not_active IP Right Cessation
- 1976-10-08 DK DK454176A patent/DK146194C/da not_active IP Right Cessation
- 1976-10-08 FI FI762875A patent/FI762875A/fi not_active Application Discontinuation
- 1976-10-08 NO NO763446A patent/NO144468C/no unknown
- 1976-10-13 NL NLAANVRAGE7611295,A patent/NL184558C/xx not_active IP Right Cessation
- 1976-10-14 FR FR7630866A patent/FR2327764A1/fr active Granted
- 1976-10-14 PH PH19008A patent/PH14513A/en unknown
- 1976-10-14 CA CA263,423A patent/CA1079641A/en not_active Expired
- 1976-10-15 IE IE2282/76A patent/IE43778B1/en not_active IP Right Cessation
- 1976-10-15 SU SU762412401A patent/SU1165223A3/ru active
- 1976-10-15 ES ES452420A patent/ES452420A1/es not_active Expired
- 1976-10-15 GB GB42907/76A patent/GB1560406A/en not_active Expired
- 1976-10-15 ZA ZA00766166A patent/ZA766166B/xx unknown
- 1976-10-15 CS CS766685A patent/CS199647B2/cs unknown
- 1976-10-15 AU AU18754/76A patent/AU508628B2/en not_active Expired
- 1976-10-15 BE BE171578A patent/BE847368A/xx not_active IP Right Cessation
- 1976-10-15 HU HU76SA00002985A patent/HU172533B/hu not_active IP Right Cessation
- 1976-10-15 PT PT65719A patent/PT65719B/pt unknown
- 1976-10-15 IL IL50686A patent/IL50686A/xx unknown
- 1976-10-15 NZ NZ182341A patent/NZ182341A/xx unknown
- 1976-10-15 AT AT767976A patent/AT362510B/de not_active IP Right Cessation
- 1976-10-16 GR GR51952A patent/GR61268B/el unknown
- 1976-10-16 JP JP51123463A patent/JPS5854122B2/ja not_active Expired
-
1982
- 1982-12-23 SG SG630/82A patent/SG63082G/en unknown
-
1983
- 1983-01-20 HK HK31/83A patent/HK3183A/xx unknown
-
1984
- 1984-12-30 MY MY63/84A patent/MY8400063A/xx unknown
Non-Patent Citations (1)
Title |
---|
Патент US 3146169, кл. 424-15, 1962. * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU1165223A3 (ru) | Способ получени эргоалкалоидов | |
US8058433B2 (en) | Crystalline pharmaceutical | |
KR100664560B1 (ko) | L(-)-카르니틴의 비흡습성 염을 제조하는 신규한 방법 | |
FI119639B (fi) | Menetelmä kiteisen vedettömän mykofenolaattimofetiilin ja sen intravenoosivalmisteen valmistamiseksi | |
EP0265226B1 (en) | Spray dried acetaminophen | |
GB2062467A (en) | Aqueous solution of nitroglycerin | |
RU2002745C1 (ru) | Способ получени кристаллов дигидрата гидрохлорида ондансетрона уменьшенного размера | |
FI70138C (fi) | Foerfarande foer framstaellning av en foerbaettrad injekterbarloesning innehaollande kalcium/magnesium/oxitetracyklinsa mklat | |
KR102090912B1 (ko) | 신규한 결정형 형태의 에독사반 및 이의 제조방법 | |
AU2006222711A1 (en) | Crystalline pharmaceutical | |
AU2001250920A1 (en) | Crystalline pharmaceutical | |
US4222939A (en) | Process for preparing solid sodium amoxycillin | |
SU1053748A3 (ru) | Способ получени тетрагидро 2 @ бензо-/ @ /-пиррола | |
WO2004011432A1 (en) | Organic acid salt of amlodipine | |
KR950007228B1 (ko) | 암로디핀의 베실레이트염 | |
RU2042686C1 (ru) | Кристаллический этопозид 4`-фосфат диэтанолсольват и способ его получения | |
SU648101A3 (ru) | Способ получени стабильной полиморфной формы 1-окси-3-(1,1-диметилгептил)-6,6-диметил-6,6а,7,8,10,10агексагидро-9н-дибензо (в, ) пиран9-она | |
CN116947850A (zh) | 一种盐酸小檗碱与间羟基苯甲酸共晶及其制备方法 | |
KR19990014934A (ko) | 피롤리디닐 메틸 인돌의 염 | |
EP2880040A1 (en) | Bortezomib esters and formulations thereof | |
SU537070A1 (ru) | Диметилбензосульфонат кускгигрина в качестве ганглиоблокатора кратковременного действи | |
ZA200206962B (en) | Crystalline pharmaceutical. | |
KR19990084651A (ko) | 안정성이 향상된 미소프로스톨 제제 및 그 제조방법 | |
RU2000123653A (ru) | Способ получения антиангинального лекарственного средства |